Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine

Transplantation

Volumn 65, Issue 3, 1998, Pages 446-449

  Satterthwaite, Roger ^a   Aswad, Saleh ^a   Sunga, Victor ^a   Shidban, Hamid ^a   Bogaard, Thomas ^a   Asai, Paul ^a   Khetan, Umakant ^a   Akra, Iklas ^a   Mendez, Rafael G ^a   Mendez, Robert ^a  

^a National Institute of Transplantation Los Angeles   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; CHOLESTEROL; CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; FEMALE; FUROSEMIDE; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEX FACTORS; TACROLIMUS;

EID: 0032519685     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00030     Document Type: Article

References (10)

1. D'Alessandro AM, Lorentzen DF, Pirsch JD, et al. Transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experience. In: Terasaki P, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1990: 239.
2. Cattran DC, Steiner G, Wilson DR, Fenton SSA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979; 91: 554.
3. Ochai T, et al. and the Japanese FK506 Study Group. Japanese multicenter studies of FK506 in renal transplantation. Transplant Proc 1995; 27(1): 50.
4. Ost I. Effects of cyclosporine on prednisolone metabolism [Letter]. Lancet 1984; 1: 451.
5. Ost I. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation 1987; 44: 533.
6. Caroll PB, Boschero AC, Li MY, Tzakis AG, Starzl TE, Atwater IJ. Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from rat islets of Langerhans. Transplantation 1992; 51: 275.
7. Bittar AE, Ratcliffe PJ, Richardson AJ, et al. The prevalence of hyperlipidemia in renal transplant recipients. Transplantation 1990; 50(6): 987.
8. DeGroen P. Cyclosporine, low density lipoprotein and cholesterol. Mayo Clin Proc 1988; 63: 1012.
9. Apanay DC, Neylan JF, Ragab MS, Sgoutas DS. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation 1994; 58(6): 663.
10. Emeson EE, Shen M-L. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporine. Am J Pathol 1993; 142(6): 1906.